VERU
VERU INC.
NASDAQ · Healthcare · Biotechnology · US
$2.41
+0.84%Next report
Analyst consensus
- Next report date
- Dec 16, 2026
- EPS estimate
- -$0.34
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.30
- EPS estimate
- -$0.32
- Revenue actual
- —
- Revenue estimate
- $1.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +13.8%
- Revenue beats (12Q)
- 2
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.32 | -$0.30 | Beat 6.25% | — |
| May 13, 2026 | -$0.31 | -$0.13 | Beat 58.06% | — |
| Feb 11, 2026 | -$0.47 | -$0.26 | Beat 44.68% | — |
| Dec 17, 2025 | -$0.39 | -$0.60 | Miss -53.85% | $247.1K |
| Aug 12, 2025 | -$0.55 | -$0.50 | Beat 9.09% | — |
| May 8, 2025 | -$0.06 | -$0.05 | Beat 16.67% | — |
| Feb 13, 2025 | -$0.08 | -$0.07 | Beat 12.50% | — |
| Dec 16, 2024 | -$0.07 | -$0.06 | Beat 14.29% | $6.7M |
| Apr 1, 2024 | -$0.10 | -$0.09 | Beat 10.00% | $2.1M |
| Dec 8, 2023 | -$0.20 | -$0.16 | Beat 20.00% | $3.9M |
| Aug 10, 2023 | -$0.20 | -$0.13 | Beat 35.00% | $3.3M |
| May 11, 2023 | -$0.33 | -$0.44 | Miss -33.33% | $6.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 16, 2026